Abstract
Pamiparib, a selective poly (ADP-ribose) polymerase 1/2 inhibitor, demonstrated tolerability and antitumor activity in patients with solid tumors at 6......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
